Literature DB >> 25383722

Development and validation of a robust and sensitive assay for the discovery of selective inhibitors for serine/threonine protein phosphatases PP1α (PPP1C) and PP5 (PPP5C).

Mark R Swingle1, Richard E Honkanen.   

Abstract

Protein phosphatase types 1 α (PP1α/PPP1C) and 5 (PP5/PPP5C) are members of the PPP family of serine/threonine protein phosphatases. PP1 and PP5 share a common catalytic mechanism, and several natural compounds, including okadaic acid, microcystin, and cantharidin, act as strong inhibitors of both enzymes. However, to date there have been no reports of compounds that can selectively inhibit PP1 or PP5, and specific or highly selective inhibitors for either PP1 or PP5 are greatly desired by both the research and pharmaceutical communities. Here we describe the development and optimization of a sensitive and robust (representative PP5C assay data: Z'=0.93; representative PP1Cα assay data: Z'=0.90) fluorescent phosphatase assay that can be used to simultaneously screen chemical libraries and natural product extracts for the presence of catalytic inhibitors of PP1 and PP5.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25383722      PMCID: PMC4229695          DOI: 10.1089/adt.2014.603

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  58 in total

1.  Determining appropriate substrate conversion for enzymatic assays in high-throughput screening.

Authors:  Ge Wu; Yue Yuan; C Nicholas Hodge
Journal:  J Biomol Screen       Date:  2003-12

2.  The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity.

Authors:  Nichole E LaPointe; Gerardo Morfini; Gustavo Pigino; Irina N Gaisina; Alan P Kozikowski; Lester I Binder; Scott T Brady
Journal:  J Neurosci Res       Date:  2009-02       Impact factor: 4.164

Review 3.  The PP1 binding code: a molecular-lego strategy that governs specificity.

Authors:  Ewald Heroes; Bart Lesage; Janina Görnemann; Monique Beullens; Luc Van Meervelt; Mathieu Bollen
Journal:  FEBS J       Date:  2012-03-21       Impact factor: 5.542

4.  Label-free quantitative proteomics and SAINT analysis enable interactome mapping for the human Ser/Thr protein phosphatase 5.

Authors:  Dana V Skarra; Marilyn Goudreault; Hyungwon Choi; Michael Mullin; Alexey I Nesvizhskii; Anne-Claude Gingras; Richard E Honkanen
Journal:  Proteomics       Date:  2011-02-25       Impact factor: 3.984

5.  Activation of protein phosphatase 5 by limited proteolysis or the binding of polyunsaturated fatty acids to the TPR domain.

Authors:  M X Chen; P T Cohen
Journal:  FEBS Lett       Date:  1997-01-02       Impact factor: 4.124

6.  Cdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound library.

Authors:  Paul A Johnston; Caleb A Foster; Marni Brisson Tierno; Tong Ying Shun; Sunita N Shinde; William D Paquette; Kay M Brummond; Peter Wipf; John S Lazo
Journal:  Assay Drug Dev Technol       Date:  2009-06       Impact factor: 1.738

7.  Identification of a functional link for the p53 tumor suppressor protein in dexamethasone-induced growth suppression.

Authors:  Gudrun Urban; Teresa Golden; Ileana V Aragon; Lex Cowsert; Scott R Cooper; Nicholas M Dean; Richard E Honkanen
Journal:  J Biol Chem       Date:  2003-01-07       Impact factor: 5.157

8.  Expression of the catalytic subunit of phosphorylase phosphatase (protein phosphatase-1) in Escherichia coli.

Authors:  A J Zhang; G Bai; S Deans-Zirattu; M F Browner; E Y Lee
Journal:  J Biol Chem       Date:  1992-01-25       Impact factor: 5.157

9.  Control of glucocorticoid and progesterone receptor subcellular localization by the ligand-binding domain is mediated by distinct interactions with tetratricopeptide repeat proteins.

Authors:  Ananya Banerjee; Sumudra Periyasamy; Irene M Wolf; Terry D Hinds; Weidong Yong; Weinian Shou; Edwin R Sanchez
Journal:  Biochemistry       Date:  2008-09-05       Impact factor: 3.162

10.  The ability to enhance the solubility of its fusion partners is an intrinsic property of maltose-binding protein but their folding is either spontaneous or chaperone-mediated.

Authors:  Sreejith Raran-Kurussi; David S Waugh
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

View more
  5 in total

1.  Crystal structures and mutagenesis of PPP-family ser/thr protein phosphatases elucidate the selectivity of cantharidin and novel norcantharidin-based inhibitors of PP5C.

Authors:  Debasish Chattopadhyay; Mark R Swingle; Edward A Salter; Eric Wood; Brandon D'Arcy; Catherine Zivanov; Kevin Abney; Alla Musiyenko; Scott F Rusin; Arminja Kettenbach; Larry Yet; Chad E Schroeder; Jennifer E Golden; Wade H Dunham; Anne-Claude Gingras; Surajit Banerjee; David Forbes; Andrzej Wierzbicki; Richard E Honkanen
Journal:  Biochem Pharmacol       Date:  2016-03-23       Impact factor: 5.858

Review 2.  Structure and function of the co-chaperone protein phosphatase 5 in cancer.

Authors:  Rebecca A Sager; Natela Dushukyan; Mark Woodford; Mehdi Mollapour
Journal:  Cell Stress Chaperones       Date:  2020-04-02       Impact factor: 3.667

3.  Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.

Authors:  Victor Clausse; Dingyin Tao; Subrata Debnath; Yuhong Fang; Harichandra D Tagad; Yuhong Wang; Hongmao Sun; Christopher A LeClair; Sharlyn J Mazur; Kelly Lane; Zhen-Dan Shi; Olga Vasalatiy; Rebecca Eells; Lynn K Baker; Mark J Henderson; Martin R Webb; Min Shen; Matthew D Hall; Ettore Appella; Daniel H Appella; Nathan P Coussens
Journal:  J Biol Chem       Date:  2019-09-03       Impact factor: 5.157

4.  Phosphatase inhibition by LB-100 enhances BMN-111 stimulation of bone growth.

Authors:  Leia C Shuhaibar; Nabil Kaci; Jeremy R Egbert; Thibault Horville; Léa Loisay; Giulia Vigone; Tracy F Uliasz; Emilie Dambroise; Mark R Swingle; Richard E Honkanen; Martin Biosse Duplan; Laurinda A Jaffe; Laurence Legeai-Mallet
Journal:  JCI Insight       Date:  2021-05-10

5.  An Ultra-High-Throughput Screen for Catalytic Inhibitors of Serine/Threonine Protein Phosphatases Types 1 and 5 (PP1C and PP5C).

Authors:  Mark Swingle; Claude-Henry Volmar; S Adrian Saldanha; Peter Chase; Christina Eberhart; Edward A Salter; Brandon D'Arcy; Chad E Schroeder; Jennifer E Golden; Andrzej Wierzbicki; Peter Hodder; Richard E Honkanen
Journal:  SLAS Discov       Date:  2016-09-27       Impact factor: 3.341

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.